Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010842 · ClinicalTrials.gov registry record · Phase 1
Natural Antioxidants in the Treatment of Multiple Sclerosis
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00010842: Completed Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00010842 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00010842, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to compare the effectiveness of three antioxidant regimens in treating the symptoms of multiple sclerosis (MS).
Interventions
- DRUG Ginkgo biloba
- DRUG Alpha-lipoic acid
- DRUG Vitamin E/Selenium
- DRUG Essential fatty acids
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-09 |
| Est. Completion | 2004-12 |
| Phase | Phase 1 |
What the finished NCT00010842 record still lists
NCT00010842 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 4 interventions - of which Ginkgo biloba is the first listed.
NCT00010842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00010842 about?
NCT00010842 is a clinical study titled "Natural Antioxidants in the Treatment of Multiple Sclerosis". The purpose of this study is to compare the effectiveness of three antioxidant regimens in treating the symptoms of multiple sclerosis (MS).
What is the current status of trial NCT00010842?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-09. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00010842?
The interventions under investigation include: Ginkgo biloba (DRUG), Alpha-lipoic acid (DRUG), Vitamin E/Selenium (DRUG), Essential fatty acids (DRUG).
Who is sponsoring clinical trial NCT00010842?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia